LABD vs LABU: Leverage, Returns & Decay

Over three months to Nov 13, 2026, against its daily multiple, compounded, LABD finished 3.8 points over and LABU 2.0 points short.

Return gap
+143.1 pts1 year to Nov 13, 2026: LABU ahead, total return
Fee gap
0.11 ptsA year: LABD 1.07%, LABU 0.96%, per filings dated Mar 3, 2026
Overlap
–No book read for both funds
Net flow
−$71m / −$50mLABD / LABU, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
LABD and LABU · 1 year

Growth of 100

LABD −72.8%LABU +70.3%
Growth of 100 in LABD and LABU over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. LABD ends at 27.2 (−72.8%), LABU at 170.3 (+70.3%).

LABD −72.8%, LABU +70.3%: LABU +143.1 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

LABD and LABU flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in LABD for 10 years at 1.07% a year costs about $1,728 in fees and lost growth; LABU at 0.96% would cost $1,557. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

LABD · 3 months to Nov 13, 202614.1 pts short of its stated multiple
14.1 pts short of its stated multipleLABD returned −0.9% while −3 times XBI's move would have been +13.2%. Data from Aug 14, 2026 to Nov 13, 2026.XBI −4.4% ×−3 implies+13.2%LABD returned−0.9%14.1 pts short of its stated multipleLABD returned −0.9% while −3 times XBI's move would have been +13.2%. Data from Aug 14, 2026 to Nov 13, 2026.XBI −4.4% ×−3 implies+13.2%LABD returned−0.9%

LABD returned −0.9% while −3 times XBI's move would have been +13.2%. Data from Aug 14, 2026 to Nov 13, 2026.

LABD returned −0.9% while −3 times XBI's move would have been +13.2%. Data from Aug 14, 2026 to Nov 13, 2026.
LABU · 3 months to Nov 13, 20269.1 pts short of its stated multiple
9.1 pts short of its stated multipleLABU returned −22.3% while 3 times XBI's move would have been −13.2%. Data from Aug 14, 2026 to Nov 13, 2026.XBI −4.4% ×3 implies−13.2%LABU returned−22.3%9.1 pts short of its stated multipleLABU returned −22.3% while 3 times XBI's move would have been −13.2%. Data from Aug 14, 2026 to Nov 13, 2026.XBI −4.4% ×3 implies−13.2%LABU returned−22.3%

LABU returned −22.3% while 3 times XBI's move would have been −13.2%. Data from Aug 14, 2026 to Nov 13, 2026.

Data from Aug 14, 2026 to Nov 13, 2026.

IQ Leverage Score

How closely it delivered its daily multiple over 3 months, ranked against 19 inverse ETFs at 3x, over three months and 31 leveraged ETFs at 3x, over three months. 100 is best.

LABU scores higher · Did it keep up with its own daily multiple, compounded day by day, over three months?

LABD among the 19 inverse ETFs at 3x, over three months

2.6, the lowest in this set97.4, the highest

LABU among the 31 leveraged ETFs at 3x, over three months

1.6, the lowest in this set98.4, the highest

A percentile among the 19 inverse ETFs at 3x, over three months. LABU is a percentile among the 31 leveraged ETFs at 3x, over three months, a different set, so the two marks are not on one scale. Three months only, against the fund's own daily multiple; a different quarter can rank it very differently.

Key numbers

LABD returned, 3 months
−0.9%
LABU returned, 3 months
−22.3%
LABD from its stated multiple: compounding −17.9 pts, gap to the daily multiple +3.8 pts
−14.1 pts
LABU from its stated multiple: compounding −7.1 pts, gap to the daily multiple −2.0 pts
−9.1 pts

LABU costs 0.11 points a year less; their one-year returns differ by 143.1 points; LABU is 6.8 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year−72.8%+70.3%
What its daily multiple gave, 3 months−4.7%−20.3%
What it tracksS&P BiotechS&P Biotech
Expense ratio1.07%0.96%
Net assets, as of Nov 12, 2026$79m$540m
Holdings in commonnot published

The numbers behind it

Net assets on Nov 12, 2026: $79m for Direxion Daily S&P Biotech Bear 3X ETF and $540m for Direxion Daily S&P Biotech Bull 3X ETF.

Side by side

Open the table
FundDirexion Daily S&P Biotech Bear 3X ETF · Aims to return three times the opposite of the daily move of biotech (XBI)Direxion Daily S&P Biotech Bull 3X ETF · Aims to return three times the daily move of biotech (XBI)
IssuerDirexionDirexion
Sets out to return−3x+3x
Underlying assetXBIXBI
Segmentsectorsector
Fund returned, 3 months−0.9%−22.3%
Underlying returned, over that window−4.4%−4.4%
What the stated multiple implies, over that window+13.2%−13.2%
Difference from stated, over that window−14.1 pts−9.1 pts
Fund returned, 1 year−72.8%+70.3%
Difference from stated, over that windownot available−35.0 pts
Underlying volatility35%35%
Expense ratio1.07%0.96%
First tradedMay 28, 2015May 28, 2015
Net assets, as of Nov 12, 2026$79m$540m

As of Nov 13, 2026. Source: ETFIQ.

The dataFull tables, method and files, one click away.

Window by window

Open the full table
1 month−14.1%+2.3%−7.8%+7.8%−6.3 pts−5.5 pts
3 months−0.9%−22.3%+13.2%−13.2%−14.1 pts−9.1 pts
6 months−48.9%+24.5%−45.9%+45.9%−3.0 pts−21.4 pts
1 year−72.8%+70.3%not meaningful+105.3%not meaningful−35.0 pts
3 years−96.0%+238.0%not meaningfulnot meaningfulnot meaningfulnot meaningful
Since launch (LABD May 2015 · LABU May 2015)−100.0%−93.0%not meaningful+285.0%not meaningful−378.0 pts

From Jun 2015 to Nov 2026, LABU returned slightly more: −93.5% to −100.0%. LABD and LABU swung about the same: 92.6% and 94.0%. LABD and LABU fell about the same at their worst: −100.0% and −99.0%.

Jun 5, 2015 to Nov 12, 2026 · 597 weekly returns · each against XBI · 19 measures

Full scorecard

Open the full table
Total return−100.0%−93.5%+90.0%LABU (slight)Price change plus distributions, reinvested.
Annualized−54.5%−21.2%+5.7%LABUTotal return as a yearly rate.
Price return−100.0%−93.7%+86.1%LABU (slight)Price change alone, distributions left out.
Volatility92.6%94.0%31.1%TieSpread of weekly returns, annualized. Lower is steadier.
Downside deviation65.7%61.9%21.0%LABU (slight)Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown−100.0%−99.0%−61.5%TieDeepest fall from a high to the low after it.
Upside capture−23.2%Not measured100.0%Share of its benchmark's rise caught in the weeks it rose.
Downside captureNot measured121.7%100.0%Share of its benchmark's fall taken in the weeks it fell. Lower is better.
Beta−2.953.011.00LABD lowerHow far it moves for each 1% its benchmark moves.
R squared0.980.991.00Not an edgeShare of its weekly moves its benchmark explains.
Sharpe−0.410.190.26LABUReturn above Treasury bills per unit of volatility.
Sortino−0.570.290.39LABUReturn above Treasury bills per unit of downside deviation.
Treynor0.1270.0590.082LABDReturn above Treasury bills per unit of beta.
Calmar−0.55−0.210.09LABUAnnualized return divided by the max drawdown.
BenchmarkXBIXBIXBIThe ETF each fund is measured against.
Alpha−13.4% a year−6.7% a year0.0%Both significantYearly return beyond what its beta to the benchmark predicts.
Alpha t-stat−3.38−3.20Not an edgeHow sure the alpha is. Below 2, it could be chance.
Alpha range−21.3% to −5.6%−10.9% to −2.6%The 95% range for the yearly alpha.
Information ratio−0.370.15LABUReturn against its benchmark per unit of tracking error.
Tracking error123.5%63.0%0.0%Not an edgeHow far weekly returns stray from the benchmark, annualized.
More

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 597 weekly returns. Cash rate: the 13-week Treasury bill.

About LABD

Over the three months to Nov 13, 2026, LABD lost 0.9%, against −4.7% for three times the inverse of XBI's daily moves. Read the multiple against the whole window instead and −3 times XBI's −4.4% implies +13.2%, which makes LABD look 14.1 points short. That is not the fund's objective, which is daily. Of that 14.1, daily compounding is −17.9 points, which any −3 times fund would show over the same path, and the fund itself is +3.8 points against −3 times each day's move, compounded. LABD aims to return -3 times XBI's move each day, then resets. Over one day it does that. Over longer periods the daily results compound, so the total is not -3 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run. XBI moved at 35% annualized over that window. The more it moves, the further the two numbers separate.

About LABU

Over the three months to Nov 13, 2026, LABU lost 22.3%, against −20.3% for three times XBI's daily moves. Read the multiple against the whole window instead and 3 times XBI's −4.4% implies −13.2%, which makes LABU look 9.1 points short. Of that 9.1, daily compounding is −7.1 points, which any 3 times fund would show over the same path, and the fund itself is −2.0 points against 3 times each day's move, compounded. LABU aims to return +3 times XBI's move each day, then resets. Over longer periods the daily results compound, so the total is not +3 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run.

Questions people ask

Which came closer to its daily multiple, LABD or LABU?

Over the window to Nov 13, 2026, LABD finished 14.1 points from what its multiple implies and LABU finished 9.1 points from its own, so LABU came closer. Neither number predicts the next window: it depends on how much the underlying moves about.

Are LABD and LABU levered on the same thing?

Yes. Both are levered on biotech, LABD at -3 times and LABU at +3 times the daily move.

Which one decays faster, LABD or LABU?

Decay follows how much the underlying moves about. Over this window LABD’s moved at 35% annualized and LABU’s at 35%, so LABD has the rougher ride and, at the same multiple, loses more to compounding.

Can I hold LABD or LABU for a year?

Both reset every day, so the multiple in the name applies to a single day, and daily results compound. Over a year the total is not the multiple times the year’s move; after a fall and recovery it is lower.

Which is cheaper, LABD or LABU?

LABD charges 1.07% a year and LABU charges 0.96%, so LABU is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, LABD against LABU, data as of Nov 13, 2026. https://etfiq.com/compare/leverage/labd-vs-labu

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.